Hypoxic pulmonary vasoconstriction
Hypoxic pulmonary vasoconstriction (HPV), also known as the Euler-Liljestrand mechanism, is a physiological phenomenon in which small pulmonary arteries constrict in the presence of alveolar hypoxia (low oxygen levels). By redirecting blood flow from poorly-ventilated lung regions to well-ventilated lung regions, HPV is thought to be the primary mechanism underlying ventilation/perfusion matching.[1][2]
The process might initially seem counterintuitive, as low oxygen levels might theoretically stimulate increased blood flow to the lungs to increase gas exchange. However, the purpose of HPV is to distribute bloodflow regionally to increase the overall efficiency of gas exchange between air and blood. While the maintenance of ventilation/perfusion ratio during regional obstruction of airflow is beneficial, HPV can be detrimental during global alveolar hypoxia which occurs with exposure to high altitude, where HPV causes a significant increase in total pulmonary vascular resistance, and pulmonary arterial pressure, potentially leading to pulmonary hypertension and pulmonary edema.
Several factors inhibit HPV including increased cardiac output, hypocapnia, hypothermia, acidosis/alkalosis, increased pulmonary vascular resistance, inhaled anesthetics, calcium channel blockers, positive end-expiratory pressure (PEEP), high-frequency ventilation (HFV), isoproterenol, nitric oxide, and vasodilators.
Molecular mechanism
The classical explanation of HPV involves inhibition of hypoxia-sensitive voltage-gated potassium channels in pulmonary artery smooth muscle cells leading to depolarization.[3][4] This depolarization activates voltage-dependent calcium channels, which increases intracellular calcium and activates smooth muscle contractile machinery which in turn causes vasoconstriction. However, later studies have reported additional ion channels and mechanisms that contribute to HPV, such as transient receptor potential canonical 6 (TRPC6) channels, and transient receptor potential vanilloid 4 (TRPV4) channels.[5][6] Recently it was proposed that hypoxia is sensed at the alveolar/capillary level, generating an electrical signal that is transduced to pulmonary arterioles through gap junctions in the pulmonary endothelium to cause HPV.[7] This contrasts with the classical explanation of HPV which presumes that hypoxia is sensed at the pulmonary artery smooth muscle cell itself.
High altitude pulmonary edema
High-altitude mountaineering can induce pulmonary hypoxia due to decreased atmospheric pressure. This hypoxia causes vasoconstriction that ultimately leads to high altitude pulmonary edema (HAPE). For this reason, some climbers carry supplemental oxygen to prevent hypoxia, edema, and HAPE. The standard drug treatment of dexamethasone does not alter the hypoxia or the consequent vasoconstriction, but stimulates fluid reabsorption in the lungs to reverse the edema. Additionally, several studies on native populations remaining at high altitudes have demonstrated to varying degrees the blunting of the HPV response.[8]
References
- ↑ Silverthorn, D.U. (2016). "Chapter 14-15". Human physiology (7th ed.). New York: Pearson Education. p. 544.
- ↑ Sylvester, J. T.; Shimoda, Larissa A.; Aaronson, Philip I.; Ward, Jeremy P. T. (2012-01-01). "Hypoxic pulmonary vasoconstriction". Physiological Reviews. 92 (1): 367–520. doi:10.1152/physrev.00041.2010. ISSN 1522-1210. PMID 22298659.
- ↑ Post, J. M.; Hume, J. R.; Archer, S. L.; Weir, E. K. (1992-04-01). "Direct role for potassium channel inhibition in hypoxic pulmonary vasoconstriction". The American Journal of Physiology. 262 (4 Pt 1): C882–890. doi:10.1152/ajpcell.1992.262.4.C882. ISSN 0002-9513. PMID 1566816.
- ↑ Yuan, X. J.; Goldman, W. F.; Tod, M. L.; Rubin, L. J.; Blaustein, M. P. (1993-02-01). "Hypoxia reduces potassium currents in cultured rat pulmonary but not mesenteric arterial myocytes". The American Journal of Physiology. 264 (2 Pt 1): L116–123. doi:10.1152/ajplung.1993.264.2.L116. ISSN 0002-9513. PMID 8447425.
- ↑ Weissmann, Norbert; Dietrich, Alexander; Fuchs, Beate; Kalwa, Hermann; Ay, Mahmut; Dumitrascu, Rio; Olschewski, Andrea; Storch, Ursula; Mederos y Schnitzler, Michael (2006-12-12). "Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchange". Proceedings of the National Academy of Sciences of the United States of America. 103 (50): 19093–19098. Bibcode:2006PNAS..10319093W. doi:10.1073/pnas.0606728103. ISSN 0027-8424. PMC 1748182. PMID 17142322.
- ↑ Goldenberg, Neil M.; Wang, Liming; Ranke, Hannes; Liedtke, Wolfgang; Tabuchi, Arata; Kuebler, Wolfgang M. (2015-06-01). "TRPV4 Is Required for Hypoxic Pulmonary Vasoconstriction". Anesthesiology. 122 (6): 1338–1348. doi:10.1097/ALN.0000000000000647. ISSN 1528-1175. PMID 25815455. S2CID 24364626.
- ↑ Wang, Liming; Yin, Jun; Nickles, Hannah T.; Ranke, Hannes; Tabuchi, Arata; Hoffmann, Julia; Tabeling, Christoph; Barbosa-Sicard, Eduardo; Chanson, Marc; Kwak, Brenda R.; Shin, Heesup S.; Wu, Songwei; Isakson, Brant E.; Witzenrath, Martin; de Wit, Cor; Fleming, Ingrid; Kuppe, Hermann; Kuebler, Wolfgang M. (2012-11-01). "Hypoxic pulmonary vasoconstriction requires connexin 40-mediated endothelial signal conduction". The Journal of Clinical Investigation. 122 (11): 4218–4230. doi:10.1172/JCI59176. ISSN 1558-8238. PMC 3484430. PMID 23093775.
- ↑ Swenson, Erik R. (24 Jun 2013). "Hypoxic Pulmonary Vasoconstriction". High Altitude Medicine & Biology. 14 (2): 101–110. doi:10.1089/ham.2013.1010. PMID 23795729.
- Von Euler US, Liljestrand G (1946). "Observations on the pulmonary arterial blood pressure in the cat". Acta Physiol. Scand. 12 (4): 301–320. doi:10.1111/j.1748-1716.1946.tb00389.x.
- Völkel N, Duschek W, Kaukel E, Beier W, Siemssen S, Sill V (1975). "Histamine-an important mediator for the Euler-Liljestrand mechanism?". Pneumonologie. Pneumonology. 152 (1–3): 113–21. doi:10.1007/BF02101579. PMID 171630. S2CID 27167180.
- Porcelli RJ, Viau A, Demeny M, Naftchi NE, Bergofsky EH (1977). "Relation between hypoxic pulmonary vasoconstriction, its humoral mediators and alpha-beta adrenergic receptors". Chest. 71 (2 suppl): 249–251. doi:10.1378/chest.71.2_Supplement.249. PMID 12924.